← FDA Drug Approvals (Drugs@FDA)

ELETRIPTAN HYDROBROMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2017-06-27

Drug application

FDA Application #

ANDA202040

Application type

Abbreviated New Drug Application (Generic)

Brand name

ELETRIPTAN HYDROBROMIDE

Generic name

ELETRIPTAN HYDROBROMIDE

Active ingredients

ELETRIPTAN HYDROBROMIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA PHARMS USA

Manufacturer

Teva Pharmaceuticals USA, Inc.

First approval

2017-06-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown